5 Podcast Episodes
Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres
Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres
On the heels of accelerated approval by the US FDA, Dr. Stephen Liu discusses trastuzumab-deruxtecan (T-DXd) with medica... Read more
12 Aug 2022
•
37mins
Lyudmila Bazhenova, MD: Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
Lyudmila Bazhenova, MD: Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
Webcast: Therapeutic Challenges in EGFR-Mutant NSCLC: Addressing Treatment Choices and Resistance
31 Oct 2018
•
20mins
Corey J. Langer, MD, Helen J. Ross, MD, Charu Aggarwal, MD, Lyudmila Bazhenova, MD: Case-based Panel Discussion on EGFR-Mutant NSCLC
Corey J. Langer, MD, Helen J. Ross, MD, Charu Aggarwal, MD, Lyudmila Bazhenova, MD: Case-based Panel Discussion on EGFR-Mutant NSCLC
Webcast: Therapeutic Challenges in EGFR-Mutant NSCLC: Addressing Treatment Choices and Resistance
31 Oct 2018
•
32mins
Lyudmila Bazhenova, MD: Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
Lyudmila Bazhenova, MD: Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
Webcast: Therapeutic Challenges in EGFR-Mutant NSCLC: Addressing Treatment Choices and Resistance
31 Oct 2018
•
20mins
Corey J. Langer, MD, Helen J. Ross, MD, Charu Aggarwal, MD, Lyudmila Bazhenova, MD: Case-based Panel Discussion on EGFR-Mutant NSCLC
Corey J. Langer, MD, Helen J. Ross, MD, Charu Aggarwal, MD, Lyudmila Bazhenova, MD: Case-based Panel Discussion on EGFR-Mutant NSCLC
Webcast: Therapeutic Challenges in EGFR-Mutant NSCLC: Addressing Treatment Choices and Resistance
31 Oct 2018
•
32mins